{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-24-000010","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.239367+00:00","generated_at":"2026-06-05T15:00:56.421392+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SI-BONE reports record Q4 revenue $38.9M (+22% YoY); FY23 revenue $138.9M (+31%); issues FY24 guidance $162-165M","bullets":["Q4 worldwide revenue $38.9M (+22% YoY); US revenue $36.7M (+22%); gross margin 74% (down from 84%) due to $1.7M excess inventory reserve.","FY23 worldwide revenue $138.9M (+31% YoY); US revenue $130.6M (+32%); net loss improved 29% to $43.3M; adjusted EBITDA loss improved 48% to $17.3M.","Over 1,600 US physicians performed >15,000 procedures in 2023; active physicians grew 22% to >1,130 in Q4.","FY24 guidance: revenue $162-165M (17-19% growth); gross margin ~78%; OpEx growth ~9%; expects significant adjusted EBITDA improvement.","Cash and equivalents ~$166M; net cash usage ~$0.8M in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-24-000010","json":"https://secwatch.observer/filing/0001459839-24-000010.json","markdown":"https://secwatch.observer/filing/0001459839-24-000010.md","text":"https://secwatch.observer/filing/0001459839-24-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000010/0001459839-24-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000010/sibn-20240226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T15:00:56.421392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d7274482e3b2ba1bfdca0aa492f6cb0b0a77956","claim":"SI-BONE, Inc. reported financial results for the quarter and year ended December 31, 2023.","evidence_excerpt":"On February 26, 2024, SI-BONE, Inc. (the \"Company\") issued a press release (the “Press Release”) announcing results for the quarter and year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1459839/000145983924000010/0001459839-24-000010-index.htm","confidence":0.4,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}